Secluded/restrained patients' perceptions of their treatment: Validity and reliability of a new questionnaire
Article first published online: 21 JUN 2012
© 2012 The Authors. Psychiatry and Clinical Neurosciences © 2012 Japanese Society of Psychiatry and Neurology
Psychiatry and Clinical Neurosciences
Volume 66, Issue 5, pages 397–404, August 2012
How to Cite
Noda, T., Sugiyama, N., Ito, H., Soininen, P., Putkonen, H., Sailas, E. and Joffe, G. (2012), Secluded/restrained patients' perceptions of their treatment: Validity and reliability of a new questionnaire. Psychiatry and Clinical Neurosciences, 66: 397–404. doi: 10.1111/j.1440-1819.2012.02350.x
- Issue published online: 26 JUL 2012
- Article first published online: 21 JUN 2012
- Received 18 February 2011; revised 27 March 2012; accepted 28 March 2012.
- patient participation;
- patient satisfaction;
- profession–patient relations
Aim: To develop a standardized self-reporting questionnaire to evaluate patients' perceptions of their overall treatment in specific relation to the use of seclusion and/or restraint (SR) measures as part of the treatment program.
Methods: A 17-item self-rating questionnaire was given to 56 patients with experience of SR-related treatment to develop a new scale, the Secluded/Restrained Patients' Perceptions of their Treatment (SR-PPT). Concurrent validity was examined against the Client Satisfaction Questionnaire-8 Japanese Version (CSQ-8J). In addition, Patient burden induced by answering the SR-PPT was evaluated.
Results: On factor analysis, two factors named as Cooperation with Staff (nine items) and Perceptions of SR (two items) were derived. Cronbach's coefficient alphas were 0.928 and 0.887, and correlation coefficients against the CSQ-8J were 0.838 and 0.609, respectively. Answering the SR-PPT was found to induce little burden on the patients.
Conclusion: Adequate internal consistency and concurrent validity of the final version of the SR-PPT, which consists of 11 items, indicate that it is acceptable as a measurement scale. Use of this questionnaire will add the patient's view to the assessment of overall treatment involving SR.